期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心肌灌注的研究进展 被引量：4

The progress of myocardium perfusion
暂未订购
导出
摘要 冠状动脉性心脏病（coronary herat disease,CHD）简称冠心病,是由于冠状动脉循环改变引起冠脉供血和心肌需求之间不平衡而导致的心肌损害,最主要的病因是冠状动脉粥样硬化.
作者 郝志茹 赵瑞平
机构地区 内蒙古医学院 内蒙古包头市中心医院心内科
出处 《中国心血管病研究》 CAS 2012年第1期66-68,共3页 Chinese Journal of Cardiovascular Research
关键词 冠状动脉疾病 心肌灌注 冠脉造影
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献15

  • 1Go RT, Marwick TH, Maelntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagaosis of coronary artery disease [ see comments ]. J Nucl Med, 1990,31 : 1899-1905.
  • 2Sampson UK, Limaye A, Dorbala S, et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography (PET-CT) in the detection of coronary artery disease. J Am Coil Cardiol, 2007,49: 1052-1058.
  • 3Omur O, Ozcan Z, Argon M, et al. A comparative evaluation of Tl-201 and Tc-99 m sestamibi myocardial perfusion spect imaging in diabetic patients. Int J Cardiac Imaging,2008,24:173-181.
  • 4Burr RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18-FDG SPECT,fluorine-18-FDG PET and rest thall-ium-201 SPECT for detection of myocardial viability. J Nucl Med Feb, 1995,36:176-179.
  • 5Nagueh SF, Vaduganathan P, Ali N, et al. Identificatim of hibernation myocardium: co-mparative accuracy of myocardial contrast echo cardiography, rest-redistribution thallium-201 tomogrsaphy and dobutamine echocardiography. J Am coil Cardiol,1997,29:985-993.
  • 6Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coil Cardiol, 1998,32: 1756-1764.
  • 7Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol, 2006,47 : 1427-1432.
  • 8Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation, 2007,115 : 1769-1776.
  • 9George RT, Jerosch-Herold M, Silva C, et al. Quantification of myocardial perfusion using dynamic 64-detector computed tomography. Invest Radiol, 2007,42 : 815-822.
  • 10Ruzsics B, Lee H, Zwerner PL, et al. Dual-energy CT of the heart for diagnosing coronary artery stenosis and myocardial ischemia-initial experience. Eur Radiol, 2008,18 : 2414-2424.

二级参考文献26

共引文献69

同被引文献34

  • 1韩雅玲,王守力,李毅,荆全民,马颖艳,王祖禄,王冬梅,栾波,王效增.急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效[J].中国介入心脏病学杂志,2005,13(1):9-12. 被引量：53
  • 2朱海云,王莉,田建明,柏挺,林琳.MRI检测活性心肌及其与冠状动脉造影、SPECT和PET对比研究[J].中国医学影像技术,2007,23(6):865-868. 被引量：13
  • 3Grines CL, Browne KF, Marco J, et al. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarc- tion. N Engl J Med, 1993,328 : 673-679.
  • 4Chi-Hang Lee, Hung-Fat Tse. Microvaseu lar obstruct ion after percutaneous coronary intervention. Catheter Cardiovasc Interv, 2010,75 .. 369-377.
  • 5Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheteriza-tion labora- tory. Catheter Cardiovasc Interv, 2008,72 : 950-957.
  • 6Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large an- terior myocardial infarction: the INFUSE-AMI randomized trial. JAMA, 2012,307 : 1817-1826.
  • 7Pasceri V, Pristipino C, Pellicia F, et al. Effects of nitric oxide donor nitroprusside on no-reflow phenomenon during coronary in- ter-vention for acute myocardial infarction. Am J Cardiol, 2005, 95 : 1358-1361.
  • 8Bates J, Baker M, Guerra R, et al. Nitric oxide generation from nitropmsside by vascular tissue-evidence that reduction of the ni- troprusside anion and cyanide loss are required. Biochem Phar- macol, 1991,42:S157-165.
  • 9Parham WA, Bouhasin A, Ciaramita JP, et al. Coronary hyper- emic dose responses of intracoronary sodium nitroprusside. Circu- lation, 2004,109 : 1236-1243.
  • 10Hillegass WB, Dean NA, Liao L, et al. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside fol- lowing percutaneous coronary interventions: Initial human clini- cal experience. J Am Coil Cardiol, 2001,37 : 1335-1343.

引证文献4

二级引证文献29

中国心血管病研究
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部